ArticlePharmaceutics2022
Engineering the Surface of Ti
Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 59 citations in OpenAlex.
- CRISPR/Cas9-Based Vanadium MXene-Free Radical Spatiotemporally Controlled Nanoreactor for Photothermal-Induced Multi-Effect Synergistic Antitumor Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Obtention and Characterization of TiOPharmaceutics · 2025Article
- PEGylated MXene@AgNP nanocomposite for targeted release of docetaxel to breast carcinoma.Therapeutic delivery · 2025Article
- Multifunctional microneedle-mediated photothermo-gas-ion synergic therapy accelerates MRSA infacted diabetic wound healing.Materials today. Bio · 2025Review
- MXene Surface Architectonics: Bridging Molecular Design to Multifunctional Applications.Molecules (Basel, Switzerland) · 2025Review
- MXene-Integrated Composites for Biomedical Applications: Synthesis, Cancer Diagnosis, and Emerging Frontiers.Small science · 2025Review
- Nano-Innovations in Cancer Therapy: The Unparalleled Potential of MXene Conjugates.Materials (Basel, Switzerland) · 2024Review
- X-ray radio-enhancement by TiBiomaterials science · 2023Article
- Development of Two-Dimensional Functional Nanomaterials for Biosensor Applications: Opportunities, Challenges, and Future Prospects.Nanomaterials (Basel, Switzerland) · 2023Review
- Self-Healing MXene- and Graphene-Based Composites: Properties and Applications.Nano-micro letters · 2023Review
- Advanced MXene-Based Micro- and Nanosystems for Targeted Drug Delivery in Cancer Therapy.Micromachines · 2022Review
- MXenes in Cancer Nanotheranostics.Nanomaterials (Basel, Switzerland) · 2022Review
- Advances of MXenes; Perspectives on Biomedical Research.Biosensors · 2022Review
- Two-dimensional ultrathin TiFrontiers in bioengineering and biotechnology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 2 countries.
Funding
Abstract
The surface of Ti
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.